0.8403USD-10.58%Mkt Cap: 12.26M USDP/E: —Last update: 2026-06-01
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized Bi…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap12.26M USD
Enterprise Value7.72M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-11.08M USD
Revenue/Share—
Last Price0.8403 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.64
PEG—
EV/EBITDA-0.66
EV/Revenue—
P/S—
P/B3.10
EPS (TTM)-1.45
EPS (Forward)-0.25
52W Range
0.28009% of range6.230
52W High6.230 USD
52W Low0.2800 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-209.37%
ROA-119.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.27M USD
CapEx (TTM)5.88K USD
FCF Margin—
FCF Yield-59.42%
Net Debt-5.70M USD
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity0.07
Current Ratio1.81
Quick Ratio1.67
Book Value/Sh0.2940 USD
Cash/Share0.4070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 7, 2016
Splits
Last Split1:16
Split DateJun 6, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)1.750 USD
Target Range1.500 USD – 2.000 USD
# Analysts2
Ownership
Shares Out.14.82M
Float14.04M
Insiders0.11%
Institutions5.33%
Short Interest
Short Ratio0.5d
Short % Float4.69%
Short % Out.4.69%
Shares Short694.91K
Short (prev mo.)809.14K
Technical
SMA 500.8544 (-1.7%)
SMA 2001.479 (-43.2%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)10.38M
Avg Vol (10d)38.32M
Technical Indicators
RSI (14)64.4
MACD-0.0226
MACD Signal-0.1159
MACD Hist.+0.0933
BB Upper0.8400 USD
BB Middle0.4384 USD
BB Lower0.0367 USD
BB Width183.25%
ATR (14)0.1226 USD
Vol Ratio (20d)0.86x